Jane Street’s OnKure Therapeutics OKUR Stock Holding History

Jane Street’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-26,812	Closed	-$111K	–	13496
2026 Q1	$111K	Buy	26,812 +7,398	+38%	+$22.8K	﹤0.01%	10586
2025 Q4	$56.3K	Buy	+19,414	New	+$58.1K	﹤0.01%	10467
2024 Q3	–	Sell	-6,204	Closed	-$93.7K	–	10593
2024 Q2	$93.7K	Buy	+6,204	New	+$105K	﹤0.01%	8752
2024 Q1	–	Sell	-7,894	Closed	-$126K	–	10244
2023 Q4	$126K	Buy	+7,894	New	+$492K	﹤0.01%	8478
2023 Q2	–	Sell	-1,974	Closed	-$118K	–	9728
2023 Q1	$118K	Buy	+1,974	New	+$71.5K	﹤0.01%	8140

Other funds holding OKUR

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street's OKUR Position: Q2 2026 in Review

Jane Street sold out of OnKure Therapeutics (OKUR) in Q2 2026, closing a stake of 26,812 shares — an estimated $111K sold.

Jane Street first reported a position in OKUR in Q1 2023 and held it in 5 quarters. The position peaked at $126K in Q4 2023. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

Jane Street reported no remaining OnKure Therapeutics position as of Q2 2026 after selling out during the quarter.
Jane Street sold 26,812 OnKure Therapeutics shares in Q2 2026, an estimated $111K.
Jane Street first reported a position in OnKure Therapeutics in Q1 2023 and held it in 5 quarters.
Jane Street's OnKure Therapeutics position peaked at $126K in Q4 2023.
75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.